Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 63351-63400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06074328
Blended Reality Immersion for Geriatric Head Trauma: The BRIGHT Study
NARecruiting
70 participants
Started: Nov 29, 2023 · Completed: Oct 1, 2025
1 condition1 sponsor1 location
NCT06154889
Rehabilitation by Multifactorial Approach After a Latarjet Procedure
NARecruiting
52 participants
Started: Nov 29, 2023 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT06047301
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
NARecruiting
234 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06179654
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
NARecruiting
36 participants
Started: Nov 29, 2023 · Completed: Oct 31, 2026
3 conditions1 sponsor1 location
NCT05815017
YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility
NARecruiting
80 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2024
7 conditions1 sponsor1 location
NCT05877729
Intervention for Virologic Suppression in Youth
NARecruiting
200 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2026
5 conditions4 sponsors1 location
NCT06113445
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)
PHASE3Active, not recruiting
467 participants
Started: Nov 29, 2023 · Completed: Feb 24, 2027
1 condition1 sponsor100 locations
NCT05890612
A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19
N/ARecruiting
3,000 participants
Started: Nov 29, 2023 · Completed: Jul 13, 2029
1 condition1 sponsor1 location
NCT06015529
Diagnostic Strategy for Suspected Pulmonary Embolism Based on 4PEPS
NAActive, not recruiting
2,951 participants
Started: Nov 29, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor23 locations
NCT06144684
A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295
PHASE1Recruiting
124 participants
Started: Nov 29, 2023 · Completed: Apr 30, 2026
2 conditions2 sponsors1 location
NCT06082804
Evaluation of Advanced Practice Nurse's Management of Patients with Chronic Myeloid Leukemia
NARecruiting
60 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06162728
Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)
PHASE1/PHASE2Recruiting
80 participants
Started: Nov 29, 2023 · Completed: Apr 1, 2026
1 condition1 sponsor32 locations
NCT05802056
Aldesleukin with Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer with Peritoneal Metastasis
PHASE1Recruiting
15 participants
Started: Nov 29, 2023 · Completed: Jan 31, 2026
5 conditions1 sponsor1 location
NCT06105918
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients with Biochemically Recurrent Prostate Cancer
PHASE1Recruiting
10 participants
Started: Nov 29, 2023 · Completed: Apr 1, 2029
2 conditions2 sponsors1 location
NCT06124248
Effectiveness of the RISE Intervention
NARecruiting
1,000 participants
Started: Nov 29, 2023 · Completed: Apr 30, 2027
2 conditions1 sponsor21 locations
NCT05468203
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
PHASE3Recruiting
3,000 participants
Started: Nov 29, 2023 · Completed: Mar 1, 2027
1 condition3 sponsors2 locations
NCT05715047
Intervention for Fatigue in HCT Recipients
NARecruiting
66 participants
Started: Nov 29, 2023 · Completed: Sep 1, 2026
2 conditions2 sponsors1 location
NCT06247449
MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer
NARecruiting
100 participants
Started: Nov 29, 2023 · Completed: Jun 1, 2028
1 condition4 sponsors1 location
NCT06101095
A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)
PHASE4Active, not recruiting
64 participants
Started: Nov 29, 2023 · Completed: Feb 1, 2028
1 condition2 sponsors30 locations
NCT05684367
Exercise to ReGain Stamina and Energy (The EXERGISE Study)
NARecruiting
24 participants
Started: Nov 29, 2023 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT05934487
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
NARecruiting
1,750 participants
Started: Nov 29, 2023 · Completed: Sep 30, 2033
3 conditions1 sponsor46 locations
NCT06148870
Comparison of Efficacy Between Two Myopia Control Lenses
NAActive, not recruiting
50 participants
Started: Nov 29, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05755997
CERebrolysin In CADASIL
PHASE2Active, not recruiting
30 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05411484
Investigation of Laser Assisted Drug Delivery of NanoDOX®
PHASE2Active, not recruiting
10 participants
Started: Nov 29, 2023 · Completed: Feb 28, 2025
1 condition2 sponsors1 location
NCT06870630
Standard Versus Oesophago-gastric Junction Complex Myotomy for Treatment naïve Type 2 Achalasia Patients
NARecruiting
158 participants
Started: Nov 29, 2023 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT05907746
Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
PHASE2Active, not recruiting
7 participants
Started: Nov 29, 2023 · Completed: Jul 31, 2028
2 conditions1 sponsor1 location
NCT06128564
A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)
PHASE2Recruiting
21 participants
Started: Nov 29, 2023 · Completed: May 30, 2033
1 condition2 sponsors7 locations
NCT06050265
Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome
NARecruiting
56 participants
Started: Nov 29, 2023 · Completed: Jul 31, 2025
3 conditions2 sponsors1 location
NCT06592404
The (Cost)Effectiveness of a Social Robot for Persons with Problems in Daily Structure and Planning in Disability Care
NARecruiting
30 participants
Started: Nov 29, 2023 · Completed: Jun 30, 2025
4 conditions9 sponsors3 locations
NCT05988073
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
N/AActive, not recruiting
413 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor113 locations
NCT06167733
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
NARecruiting
98 participants
Started: Nov 29, 2023 · Completed: Oct 28, 2025
1 condition1 sponsor7 locations
NCT06361303
The Happiest Baby, Inc. SNOO Postmarket Surveillance Study
N/ARecruiting
1,000 participants
Started: Nov 29, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT05359367
A Novel Approach to Enhance True Recovery After Stroke
N/ARecruiting
30 participants
Started: Nov 29, 2023 · Completed: Jun 15, 2026
4 conditions2 sponsors1 location
NCT06166056
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis
PHASE1/PHASE2Recruiting
45 participants
Started: Nov 29, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor9 locations
NCT06192225
Peri-operative Slow-paced Breathing to Reduce Anxiety in Breast Cancer Surgery Patients
NARecruiting
150 participants
Started: Nov 29, 2023 · Completed: Nov 2, 2025
1 condition1 sponsor1 location
NCT05745038
A Single Arm Pilot Trial of a Social Network Intervention
NARecruiting
220 participants
Started: Nov 29, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT06060405
Durvalumab and Oleclumab in Resectable PDAC
PHASE2Recruiting
22 participants
Started: Nov 29, 2023 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT06161363
Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus
N/ARecruiting
50 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06227585
Feasibility Study for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery
PHASE2Recruiting
80 participants
Started: Nov 29, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06175585
Construction of Theoretical Model of Medical Treatment Behavior of Patients With Chronic Kidney Disease
N/ARecruiting
80 participants
Started: Nov 29, 2023 · Completed: Dec 29, 2024
3 conditions1 sponsor1 location
NCT05762536
Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC
PHASE2Recruiting
245 participants
Started: Nov 29, 2023 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT06160557
A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma
N/AEnrolling by invitation
40 participants
Started: Nov 29, 2023 · Completed: Dec 1, 2027
3 conditions1 sponsor1 location
NCT05830058
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
PHASE2Recruiting
32 participants
Started: Nov 29, 2023 · Completed: Feb 3, 2027
4 conditions2 sponsors1 location
NCT05712694
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
PHASE3Recruiting
300 participants
Started: Nov 29, 2023 · Completed: Dec 30, 2027
1 condition1 sponsor30 locations
NCT06616389
Study of ODX (OsteoDex) in Multiple Myeloma
PHASE1/PHASE2Recruiting
12 participants
Started: Nov 29, 2023 · Completed: Jan 30, 2026
1 condition1 sponsor2 locations
NCT06073379
Efficacy of Korean Manupuncture on Pain in Women With Endometriosis: a Parallel-group Randomized Controlled Trial
NARecruiting
60 participants
Started: Nov 29, 2023 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT06304701
Handwritten Text Production in Adults With Autism
NARecruiting
38 participants
Started: Nov 29, 2023 · Completed: May 31, 2025
1 condition2 sponsors1 location
NCT05935358
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
PHASE4Recruiting
28 participants
Started: Nov 28, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor18 locations
NCT06205108
Pulsed tVNS Protocol and Reinforcement Learning
NARecruiting
40 participants
Started: Nov 28, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06110650
A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma
NANot yet recruiting
29 participants
Started: Nov 28, 2023 · Completed: Aug 15, 2025
1 condition1 sponsor0 locations